Measurable Residual Disease Testing Using Next-Generation Sequencing in Acute Myeloid Leukemia

Ann Lab Med. 2023 Jul 1;43(4):323-324. doi: 10.3343/alm.2023.43.4.323. Epub 2023 Feb 24.
No abstract available

Keywords: Acute myeloid leukemia; High-throughput nucleotide sequencing; Measurable residual disease.

Publication types

  • Editorial
  • Comment

MeSH terms

  • High-Throughput Nucleotide Sequencing
  • Humans
  • Leukemia, Myeloid, Acute* / diagnosis
  • Leukemia, Myeloid, Acute* / genetics
  • Mutation